Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family.
Thorncroft, Mary R
White, Gavin R M
Greaves, M J
Spreadborough, Anne R
Tricker, K J
Birch, Jillian M
Evans, D Gareth R
Camplejohn, R S
Boyle, John M
AffiliationCRC Section of Molecular Genetics, Paterson Institute for Cancer Research, Manchester, UK.
MetadataShow full item record
AbstractWe report an extensive Li-Fraumeni-like family in which there is an unusual spectrum of tumours at relatively late onset. A germline TP53 splice donor mutation in exon 4 is present in all affected family members available for testing. The mutation abolishes correct splicing of intron 4 and techniques of RT-PCR have identified three different aberrant transcripts from the mutant TP53 allele. Using the yeast functional assay to analyse transcripts in cells from a number of family members with the mutant allele, TP53 appears wild-type. Functional studies have been carried out on cells from patients with and without cancer who carry the germline mutation, and on cells from unaffected individuals from the same family who do not carry the mutation. Using a number of functional endpoints known to distinguish between cells carrying mutant or wild-type TP53 alleles, we were unable to discriminate normal (wt/wt) from heterozygous (wt/mut) cells by lymphocyte apoptosis and fibroblast survival following low dose rate ionising radiation exposure. However germline mutation carriers show increased sensitivity to radiation-induced chromosome damage in the G2 phase of the cell cycle, and decreased transient and permanent G1 arrest. These studies demonstrate the importance of fully characterising the effects of TP53 germline mutations, and may explain some of the phenotypic features of this family.
CitationGenetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. 1998, 16 (25):3291-8 Oncogene
- Characterization of germline TP53 splicing mutations and their genetic and functional analysis.
- Authors: Varley JM, Attwooll C, White G, McGown G, Thorncroft M, Kelsey AM, Greaves M, Boyle J, Birch JM
- Issue date: 2001 May 10
- Heterozygous TP53stop146/R72P fibroblasts from a Li-Fraumeni syndrome patient with impaired response to DNA damage.
- Authors: De Moura J, Kavalec FL, Doghman M, Rosati R, Custodio G, Lalli E, Cavallari GM, Santa Maria J, Figueiredo BC
- Issue date: 2010 Apr
- A Li-Fraumeni syndrome family with retained heterozygosity for a germline TP53 mutation in two tumors.
- Authors: Trkova M, Foretova L, Kodet R, Hedvicakova P, Sedlacek Z
- Issue date: 2003 Aug
- Heterogeneity in Li-Fraumeni families: p53 mutation analysis and immunohistochemical staining.
- Authors: MacGeoch C, Turner G, Bobrow LG, Barnes DM, Bishop DT, Spurr NK
- Issue date: 1995 Mar
- Cancer phenotype correlates with constitutional TP53 genotype in families with the Li-Fraumeni syndrome.
- Authors: Birch JM, Blair V, Kelsey AM, Evans DG, Harris M, Tricker KJ, Varley JM
- Issue date: 1998 Sep 3